These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28853405)

  • 1. Ketamine-ECT Study - Author's reply.
    Anderson IM
    Lancet Psychiatry; 2017 Sep; 4(9):662. PubMed ID: 28853405
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketamine-ECT Study.
    McDaniel W; Vyas B; Laguerta N
    Lancet Psychiatry; 2017 Sep; 4(9):662. PubMed ID: 28853407
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketamine and ECT: better alone than together?
    Kellner CH; Iosifescu DV
    Lancet Psychiatry; 2017 May; 4(5):348-349. PubMed ID: 28359863
    [No Abstract]   [Full Text] [Related]  

  • 4. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
    Altinay M; Karne H; Anand A
    Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
    Zhang J; Tian H; Li J; Ji S; Chen S; Zhu J; Jiang D; Wang L; Li G; Chen M; Wang W; Lin X; Zhuo C
    Psychiatry Res; 2020 May; 287():112907. PubMed ID: 32179210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.
    Rybakowski JK; Bodnar A; Krzywotulski M; Chlopocka-Wozniak M; Michalak M; Rosada-Kurasinska J; Bartkowska-Sniatkowska A
    J ECT; 2016 Sep; 32(3):164-8. PubMed ID: 27008330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.
    Yoosefi A; Sepehri AS; Kargar M; Akhondzadeh S; Sadeghi M; Rafei A; Alimadadi A; Ghaeli P
    J ECT; 2014 Mar; 30(1):15-21. PubMed ID: 24091902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trial.
    Salehi B; Mohammadbeigi A; Kamali AR; Taheri-Nejad MR; Moshiri I
    Ann Card Anaesth; 2015; 18(4):486-90. PubMed ID: 26440233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine and electroconvulsive therapy: so happy together?
    Cobb K; Nanda M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):459-462. PubMed ID: 29794567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study.
    Järventausta K; Chrapek W; Kampman O; Tuohimaa K; Björkqvist M; Häkkinen H; Yli-Hankala A; Leinonen E
    J ECT; 2013 Sep; 29(3):158-61. PubMed ID: 23475029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy.
    Allen AP; Naughton M; Dowling J; Walsh A; O'Shea R; Shorten G; Scott L; McLoughlin DM; Cryan JF; Clarke G; Dinan TG
    J Psychiatr Res; 2018 May; 100():24-32. PubMed ID: 29475018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial pre-ECT ketamine infusion in a patient with treatment-resistant depression.
    Sultan R; Riva-Posse P; Garlow SJ; Schwartz AC
    Psychosomatics; 2014; 55(4):396-399. PubMed ID: 24735865
    [No Abstract]   [Full Text] [Related]  

  • 19. S -ketamine compared to etomidate during electroconvulsive therapy in major depression.
    Zavorotnyy M; Kluge I; Ahrens K; Wohltmann T; Köhnlein B; Dietsche P; Dannlowski U; Kircher T; Konrad C
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):803-813. PubMed ID: 28424861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
    Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
    Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.